CN
菜单
Media Center
Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901
2023年04月24日
Special report 2023: Meet 20 women reshaping biopharma
China approves its first gene therapy for rare disease hemophilia B